BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 22955019)

  • 1. Renal disease in scleroderma: an update on evaluation, risk stratification, pathogenesis and management.
    Shanmugam VK; Steen VD
    Curr Opin Rheumatol; 2012 Nov; 24(6):669-76. PubMed ID: 22955019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Scleroderma renal crisis.
    Bose N; Chiesa-Vottero A; Chatterjee S
    Semin Arthritis Rheum; 2015 Jun; 44(6):687-94. PubMed ID: 25613774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent Developments in the Classification, Evaluation, Pathophysiology, and Management of Scleroderma Renal Crisis.
    Ghossein C; Varga J; Fenves AZ
    Curr Rheumatol Rep; 2016 Jan; 18(1):5. PubMed ID: 26711696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management review of scleroderma renal crisis: An update with practical pointers.
    Foocharoen C; Tonsawan P; Pongkulkiat P; Anutrakulchai S; Mahakkanukrauh A; Suwannaroj S
    Mod Rheumatol; 2023 Jan; 33(1):12-20. PubMed ID: 35349704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Scleroderma renal crisis.
    Mouthon L; Bussone G; Berezné A; Noël LH; Guillevin L
    J Rheumatol; 2014 Jun; 41(6):1040-8. PubMed ID: 24833760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal Disease and Systemic Sclerosis: an Update on Scleroderma Renal Crisis.
    Cole A; Ong VH; Denton CP
    Clin Rev Allergy Immunol; 2023 Jun; 64(3):378-391. PubMed ID: 35648373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-RNA polymerase III antibodies in the diagnosis of scleroderma renal crisis in the absence of skin disease.
    Bhavsar SV; Carmona R
    J Clin Rheumatol; 2014 Oct; 20(7):379-82. PubMed ID: 25275766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A "silent" course of normotensive scleroderma renal crisis: case report and review of the literature.
    Akoglu H; Atilgan GK; Ozturk R; Yenigun EC; Gonul II; Odabas AR
    Rheumatol Int; 2009 Aug; 29(10):1223-9. PubMed ID: 19048256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A retrospective clinical analysis of 16 patients with scleroderma renal crisis].
    Zhou J; Xu D; Hou Y; Wang Q; Li M; Zeng X
    Zhonghua Nei Ke Za Zhi; 2015 Feb; 54(2):125-9. PubMed ID: 25907843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Scleroderma renal crisis: a rare but severe complication of systemic sclerosis.
    Mouthon L; Bérezné A; Bussone G; Noël LH; Villiger PM; Guillevin L
    Clin Rev Allergy Immunol; 2011 Apr; 40(2):84-91. PubMed ID: 20012923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk Factors for Future Scleroderma Renal Crisis at Systemic Sclerosis Diagnosis.
    Gordon SM; Stitt RS; Nee R; Bailey WT; Little DJ; Knight KR; Hughes JB; Edison JD; Olson SW
    J Rheumatol; 2019 Jan; 46(1):85-92. PubMed ID: 30008456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis, management and prevention of scleroderma renal disease.
    Penn H; Denton CP
    Curr Opin Rheumatol; 2008 Nov; 20(6):692-6. PubMed ID: 18946330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal Involvement in Systemic Sclerosis: An Update.
    Chrabaszcz M; Małyszko J; Sikora M; Alda-Malicka R; Stochmal A; Matuszkiewicz-Rowinska J; Rudnicka L
    Kidney Blood Press Res; 2020; 45(4):532-548. PubMed ID: 32521536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Scleroderma Renal Crisis: Risk Factors for an Increasingly Rare Organ Complication.
    Moinzadeh P; Kuhr K; Siegert E; Blank N; Sunderkoetter C; Henes J; Krusche M; Schmalzing M; Worm M; Schmeiser T; Günther C; Aberer E; Susok L; Riemekasten G; Kreuter A; Zeidler G; Juche A; Hadjiski D; Müller-Ladner U; Gaebelein-Wissing N; Distler JHW; Sárdy M; Krieg T; Hunzelmann N
    J Rheumatol; 2020 Feb; 47(2):241-248. PubMed ID: 30936287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-terminal pro Brain Natriuretic Peptide as predictor of outcome in scleroderma renal crisis.
    Chighizola CB; Pregnolato F; Meroni PL; Denton CP; Ong VH
    Clin Exp Rheumatol; 2016; 34 Suppl 100(5):122-128. PubMed ID: 27056603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Steroid-induced scleroderma renal crisis in an at-risk patient.
    Toescu SM; Mansell A; Dinneen E; Persey M
    BMJ Case Rep; 2014 Nov; 2014():. PubMed ID: 25395468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Scleroderma renal crisis as an initial presentation of systemic sclerosis: a case report and review of the literature.
    Logee KM; Lakshminarayanan S
    Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S171-4. PubMed ID: 25797912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal involvement in systemic sclerosis.
    Scheen M; Dominati A; Olivier V; Nasr S; De Seigneux S; Mekinian A; Issa N; Haidar F
    Autoimmun Rev; 2023 Jun; 22(6):103330. PubMed ID: 37031831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of kidney involvement in systemic sclerosis: From scleroderma renal crisis to subclinical renal vasculopathy.
    Gigante A; Leodori G; Pellicano C; Villa A; Rosato E
    Am J Med Sci; 2022 Nov; 364(5):529-537. PubMed ID: 35537505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Scleroderma renal crisis in a Swedish systemic sclerosis cohort: survival, renal outcome, and RNA polymerase III antibodies as a risk factor.
    Hesselstrand R; Scheja A; Wuttge DM
    Scand J Rheumatol; 2012 Feb; 41(1):39-43. PubMed ID: 22044051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.